Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
The biggest week of Q3 reporting season begins Monday. UnitedHealth Group and Johnson & Johnson both report before the open on October 13. The bank wave follows: Bank of America and State Street post Tuesday morning, then BNY Mellon and Charles Schwab on Wednesday. European banks join in, with releasing Q3 figures on October 15. UnitedHealth carries an RSI below 41, pointing to a stock already under pressure heading into the print.
TD Cowen swept price targets lower across five US defense names on Friday. L3Harris Technologies took the sharpest reduction, down 24% to $280, though the analyst kept a Buy. RTX Corporation, Lockheed Martin, Northrop Grumman and Howmet Aerospace all saw targets trimmed. The cuts sit awkwardly beside Japan's machine tool orders, which jumped 63% year-on-year in August, according to ORTEX Alt Data from the Japan Machine Tool Builders' Association. That kind of industrial surge typically feeds defense and aerospace supply chains rather than compressing them.
Ambarella is the standout options story today. An unconfirmed M&A rumour is circulating, lifting call activity. NVIDIA and Micron lead the broader chip sector for positive options bets this week. Fastly shares are also soaring today, adding to a busy session in tech.
Short interest in MMED hit 102.9% of free float, up 24 points in a week, the largest single-week jump across US names above $500 million market cap. Wolfspeed sits at 84.2% SI % FF with availability dried to zero. On the analyst side, UBS made two notable asset manager moves: upgrading T. Rowe Price to Neutral and initiating Franklin Templeton with a Buy and a $40 target, 74% above its prior target, implying 23% upside.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
